Bad news: if you were still hoping to get one of the $400 juicers from Juicero, you may be out of luck. Juicero announced that they were suspending sales while they seek an acquirer. They'd already dropped the juicer's price from its initial $700 earlier this year and had hoped to find ways to drop it further, but ran out of time. I keep thinking: if they'd been a health care company, they not only might still be in business but also would probably be looking to raise their prices. Juicero once was the darling of investors. It raised $120 million from a variety of respected funding sources, including Kleiner Perkins, Alphabet and Campbell Soup. They weren't a juice company, or even an appliance company. They were a technology company! They had an Internet-of-Things product! They had an ongoing base of customers...
pharmaceutical industry
See the following -
FDA Inaction On Antibiotics Is Making The World Deadlier
This month, the U.S. Food and Drug Administration issued a guidance document (PDF) on the use of antibiotics in farm animals, which accounts for four-fifths of all antibiotics administered in the U.S. [...] The FDA suggests pharmaceutical companies voluntarily change a few labeling and marketing practices to help address that problem. Read More »
- Login to post comments
Free Drugs? India Mulls a New Assault on Big Pharma
...now it seems India is considering offering generic drugs for free to patients at government-run clinics. After Prime Minister Manmohan Singh backed the scheme, the Planning Commission has reportedly allocated $18 million to start the ball rolling.
- Login to post comments
Getting To The Right Relationship Between Doctors And Drug Companies
The pharmaceutical industry is held in remarkably low esteem right now. It's seen as a bunch of nefarious pushers who pay off vulnerable doctors to prescribe their latest expensive, mediocre product. Physicians who work with pharma companies are considered especially suspect, routinely described as "cozy," "in bed with industry," and "on the take." Read More »
- Login to post comments
GSK Expands Open-Source Research Project In TB
GlaxoSmithKline (GSK) has screened its entire pharmaceutical compound library of more two million compounds and identified about 200 hits with potential against tuberculosis (TB), which it will make available to external research teams as part of its drive towards an 'open innovation' approach to R&D. Read More »
- Login to post comments
Health Care's Juicero Problem
- Login to post comments
Health Committee: Hidden Trial Data Should Be Opened Up
The pharmaceutical industry should introduce a new code of practice, ensuring negative trial data cannot be hidden, according to the government’s Health Committee. Read More »
- Login to post comments
Health IT M&A Highly 'Active' Through First Half Of 2013
For the first half of 2013, health information technology saw more action in mergers and acquisitions than segments like healthcare business services, consumer health and pharma IT, according to a new report from New York-based investment bank Berkery Noyes. Read More »
- Login to post comments
Health IT M&A Very Active In First Half Of 2013
During the first six months of 2013, health information technology was the "most active market segment" of the healthcare/pharma/IT industry for mergers and acquisitions, according to investment bank Berkery Noyes. Read More »
- Login to post comments
How Cloud-Based Tools Can Help With FDA Compliance
These days, enforcing FDA compliance and mentoring new team members are more challenging than ever, thanks to a workforce that is more remote, international, and diverse. [...] With these changes, pharmaceutical companies need to adapt to grow and ride the cost-conscious trend just to survive... Read More »
- Login to post comments
How Secrecy in Medical Research Harms our Health
Medical research data remain shrouded in secrecy. As a result the data is distorted and misrepresented by pharmaceutical companies launching new medicines to exaggerate their efficacy, minimize their harmful side effects, and conceal the fact that these products are often no more effective than those already on the market. Clinical trials are unnecessarily repeated and overall, health-care and patients suffer. Read More »
- Login to post comments
i2b2 Open Source Software Boosts HIE, Biomedical Research
The health informatics software i2b2 — Informatics for Integrating Biology and the Bedside — was started in 2006, and has become something of a building block for several health information networks and research projects in genomics, pharmaceuticals and population health. Read More »
- Login to post comments
Incoming President Of IOM Outed As Member Of Boards Of Alnylam Pharmaceuticals, Medtronic And Pepsico
We just discussed how the new CEO of the National Quality Forum was revealed to be a member of the board of directors of Premier Inc, and discussed the implications of this apparently intense conflict of interest. Read More »
- Login to post comments
Indian Pharma Industry Should Work For Inventing New Drugs, Dr Abdul Kalam
The Indian pharmaceutical industry should turn their attention to invent new drugs from molecule levels and each manufacturing unit should try to become invention centres, opined Dr APJ Abdul Kalam, former President of India. Read More »
- Login to post comments
Industrial Revolution Unravels, Collaborative Economy Rises Says Jeremiah Owyang
Just about anyone who works at analyzing social media knows the name Jeremiah Owyang. He was, after all, one of the first to accurately predict social media would take the world by storm--a contrarian view back in the day when nearly everyone was convinced social media was only a fad. Now he's predicting that the industrial revolution is about to completely unravel and be replaced by a new collaborative economy... Read More »
- Login to post comments
Internationalization and Localization of Open Source Clinical Research Tools
Clinovo, the company that created ClinCapture, an open-source Electronic Data Capture (EDC) platform for clients in the pharma and life sciences space, recently localized ClinCapture to Russian for Synergy Research Group (SRG). SRG, the fastest growing Clinical Research Organization (CRO) in Russia and Eastern Europe, is the latest company to join Clinovo's CRO partners group. I thought I would share some of Clinovo's best practices for language localization.